comparemela.com

Latest Breaking News On - Master trial - Page 1 : comparemela.com

Optimizing Bispecific Use in Multiple Myeloma Treatment

A key opinion leader explores the integration of bispecifics into MM therapy regimens.

Conference perspectivesMultiple myelomaBispecific useMaster trialDurable responseFour drug combination

ASH 2023: PERSEUS Trial Overview

Rafael Fonseca, MD, discusses findings from the PERSEUS trial presented in December at ASH 2023.

Conference perspectivesMultiple myelomaAmerican society of hematologyNewly diagnosed multiple myelomaTriplet therapyQuadruplet therapyPerseus trialTransplant eligibleMaster trialDurable responseFour drug combination

Treatment Duration in Patients With Newly Diagnosed Multiple Myeloma

A panel of experts reflects on treatment duration and its role in optimizing management of patients with newly diagnosed multiple myeloma.

Evolving treatment paradigmMultiple myelomaRecent updatesPatients with newly diagnosed multipleMyeloma cancerNewly diagnosed multiple myelomaGriffin trialGriffin studyMaster trialMcmaster studyDuration of therapyDuration of treatmentDiscontinuing therapyStopping therapyFixed duration therapyMinimal residual disease

Dr Callander on Ongoing and Future Clinical Trials in Multiple Myeloma at Carbone Cancer Center

Natalie S. Callander, MD, discusses several ongoing and planned clinical trials evaluating the use of novel therapeutic regimens in multiple myeloma.

University of wisconsinUnited statesNatalies callanderDivision of hematologyCarbone cancer centerUniversity of wisconsin school medicineDepartment of medicinePublic healthMedical oncologyPalliative careWisconsin schoolUniversity of wisconsin school medicine and public healthUniversity of wisconsin carbone cancer centerMaster trialPatients with multiple myeloma

Dr Callander on Investigational Maintenance Regimens in Multiple Myeloma

Natalie S. Callander, MD, discusses the significance of the phase 3 ATLAS, phase 2 FORTE, and phase 2 MASTER trials in patients with multiple myeloma.

University of wisconsinUnited statesPublic healthDivision of hematologyUniversity of wisconsin school medicineDepartment of medicineMedical oncologyPalliative careWisconsin schoolNatalies callanderUniversity of wisconsin school medicine and public healthUniversity of wisconsin carbone cancer centerAtlas trialForte trialMaster trialPatients with multiple myeloma

vimarsana © 2020. All Rights Reserved.